Jump to content

Ç›˜ç‚¹ï¼š2024å¹´å…¨çƒå大畅销è¯ç‰ 推è阅读: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 November 2025

  • curprev 18:0318:03, 30 November 2025 SteveSchmitz1 talk contribs 5,114 bytes +5,114 Created page with "<br><br><br>罗氏与诺华联合开发的首款VEGF单抗雷珠单抗曾在2014年创下40亿美元的销售峰值,不过后来逐渐被再生元的第二代VEGF单抗阿柏西普冲击,销售额一路下滑,2023年仅剩19.35亿美元。 而随着Vabysmo的上市,阿柏西普也受到挑战,2023年销售额93.8亿美元,同比下滑3%。 这份名单上唯一的疫苗——默沙东的人瘤病毒疫苗Gardasil在2024年的销售额下降了3%,共创造..."